Wikidata

(Q62809858)

English

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Subjects With Aggressive B-Cell Non-Hodgkin Lymphoma

clinical trial

In more languages

Statements

short name
TRANSCENDWORLD (English)
0 references
title
A Phase 2, Single-arm, Multi-center Trial to Determine the Efficacy and Safety of JCAR017 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or With Other Aggressive B-Cell Malignancies (English)
0 references
sponsor
Celgene
0 references
country
Austria
0 references
Belgium
0 references
Finland
0 references
France
0 references
Germany
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
5 June 2018
0 references
end time
2 August 2022
0 references
number of participants
124
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62809858&oldid=2148546620"